Wednesday, February 16, 2022

Informa to sell Pharma Intelligence for £1.9bn to Warburg Pincus

By Andrew Kersley

International B2B and business intelligence group Informa has announced the sale of its Pharma Intelligence operation to private equity firm Warburg Pincus for a fee totalling £1.9bn.

A leading provider of specialist intelligence and data for clinical trials, drug development and regulatory compliance, Pharma Intelligence accounted for 40% of the £305m revenues reported for the company’s Informa Intelligence division in 2020.

Informa will retain a 15% stake in the business going forward and has also announced plans for a new round of share buybacks.

SourceInforma

Deal value: £1.9bn

Country: UK

Status: Announced

No comments: